Simpler stomach bug treatment on the horizon?
NCT ID NCT06977841
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested different combinations of the acid-blocker tegoprazan with antibiotics to treat H. pylori, a common stomach infection. 640 adults who had never been treated before received one of several drug regimens for 14 days. The goal was to see which combination worked best with the fewest side effects, aiming to simplify treatment and reduce antibiotic resistance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tegoprazan (a stomach acid blocker) combined with antibiotics (amoxicillin or tetracycline)
What this could lead to
If successful, this could lead to simpler, better-tolerated treatment regimens for H. pylori infection, reducing side effects and antibiotic resistance.
What could go wrong
This is a completed trial, but results are not yet published. The new drug combinations may not be more effective than current standard treatments, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhongshan Hospital (Xiamen), Fudan University
Xiamen, Fujian, 361015, China